Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Stroke therapy - study shows positive effects of Urokinase


Mechanical removal of blood clots is the therapy of choice for stroke patients. Peripheral, small blood vessels with reduced or blocked patency are, however, problematic. The study by the Department of Neurology and the University Institute for Diagnostic and Interventional Neuroradiology at Inselspital, Bern University Hospital, and the University of Bern demonstrates clear advantages of a simultaneous intra-arterial administration of Urokinase, a blood-clot-dissolving substance (thrombolytic).

Since 2015, the mechanical removal of the blood clot (endovascular mechanical thrombectomy) has been the standard procedure for treating patients with an occluded cerebral artery (stroke).

Mechanische Thrombektomie nach Stroke

J. Gralla, University Hospital Berne

Several randomized studies have shown that there is a relevant reduction in the degree of disability among stroke patients with this therapy.

Endovascular mechanical thrombectomy has been routinely performed at Inselspital since 2010. Between 300-400 patients are treated at Neurozentrum every year. Currently, the scientific focus in the area of endovascular stroke therapy lies primarily on expanding the area of use for the procedure, organizing stroke networks as well as improving the restoration of blood flow (reperfusion).

Objective: To improve the patency of blood vessels

In a meta-analysis published in 2018 (doi: 10.1136/jnnp-2017-317602), the research team led by Dr. Kaesmacher, Prof. Gralla and Prof. Fischer was able to show that there was a statistically significant and relevant difference for the patient as to whether the brain tissue is completely (so-called TICI3 result) or almost completely refused (so-called TICI2b result)1 with mechanical thrombectomy.

Therefore, intensive research is being conducted into ways of further improving reperfusion when no further mechanical improvements can be achieved. Apart from invasive rescue treatments such as inserting a permanent stent into a cerebrovascular vessel, a recently published study in Bern showed that the administration of coagulation-dissolving medicines (thrombolytics) through the catheter could improve the reperfusion result and thus reduce the degree of disability, without increasing the risk of bleeding.

Dr. Kaesmacher reports: “Until now, the significance of administering intra-arterial thrombolytic medicines following mechanical thrombectomy has not been clarified.

Accordingly, the recommendation of the American Stroke Association regarding its use has been cautious. The published results of the study thus constitute an important component in defining the future significance of the intra-arterial administration of fibrinolytics.”

Intra-arterial dissolution of blood clots has potential for improvement

The patients analyzed in the study (doi: 10/1001/jamaneurol.2019.4192) published in JAMA Neurology showed residual peripheral occlusions subsequent to mechanical thrombectomy, which led to an almost complete rather than a complete reperfusion.

The authors of the study were able to show that these peripheral occlusions could often be dissolved with the intra-arterial administration of a special thrombolytic (Urokinase) and thereby further improve reperfusion.

This was also reflected in a better outcome among the patients. In particular, it is important to note that the study found no increased risk of bleeding following the additional intra-arterial administration of Urokinase. The risk of symptomatic bleeding after the intra-arterial administration of Urokinase was 5.2% and 6.9% in the control group.

“Further studies are still needed for a widespread use of this procedure, and a pan-European, multicenter study is already well under way,” explains Prof. Dr. Jan Gralla, the neuroradiological senior author of the study. Co-supervisor of the study, Prof. Dr. Urs Fischer, summarizes: “The chosen approach constitutes a promising therapeutic strategy with which the therapeutic benefit of endovascular stroke treatment can be further improved. For patients with a low risk of bleeding, this means it is now more important than ever to do everything possible to further improve the reperfusion result.”

Wissenschaftliche Ansprechpartner:

- Prof. Dr. med. Jan Gralla
- Prof. Dr. med. Urs Fischer
- Dr. med. J. Kaesmacher


Kaesmacher J, Bellwald S, Dobrocky T. 2019: Safety and Efficacy of Intra-arterial Urokinase After Failed, Unsuccessful or incomplete Mechanical Thrombectomy in Anterior Circulation Large-Vessel Occlusion Stroke; doi: 10/1001/jamaneurol.2019.4192

Marcel Wyler | Universitätsspital Bern
Further information:

Further reports about: STROKE Urokinase blood flow blood vessels brain tissue stroke therapy thrombolytic

More articles from Medical Engineering:

nachricht Smartphone cameras can speed up urinary tract infection diagnosis
08.01.2020 | University of Bath

nachricht Livestream from the Digestive System: Magnet-Guided Camera Capsules for More Pleasant Gastroscopies
06.01.2020 | Fraunhofer-Institut für Zuverlässigkeit und Mikrointegration IZM

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Miniature double glazing: Material developed which is heat-insulating and heat-conducting at the same time

Styrofoam or copper - both materials have very different properties with regard to their ability to conduct heat. Scientists at the Max Planck Institute for Polymer Research (MPI-P) in Mainz and the University of Bayreuth have now jointly developed and characterized a novel, extremely thin and transparent material that has different thermal conduction properties depending on the direction. While it can conduct heat extremely well in one direction, it shows good thermal insulation in the other direction.

Thermal insulation and thermal conduction play a crucial role in our everyday lives - from computer processors, where it is important to dissipate heat as...

Im Focus: Fraunhofer IAF establishes an application laboratory for quantum sensors

In order to advance the transfer of research developments from the field of quantum sensor technology into industrial applications, an application laboratory is being established at Fraunhofer IAF. This will enable interested companies and especially regional SMEs and start-ups to evaluate the innovation potential of quantum sensors for their specific requirements. Both the state of Baden-Württemberg and the Fraunhofer-Gesellschaft are supporting the four-year project with one million euros each.

The application laboratory is being set up as part of the Fraunhofer lighthouse project »QMag«, short for quantum magnetometry. In this project, researchers...

Im Focus: How Cells Assemble Their Skeleton

Researchers study the formation of microtubules

Microtubules, filamentous structures within the cell, are required for many important processes, including cell division and intracellular transport. A...

Im Focus: World Premiere in Zurich: Machine keeps human livers alive for one week outside of the body

Researchers from the University Hospital Zurich, ETH Zurich, Wyss Zurich and the University of Zurich have developed a machine that repairs injured human livers and keep them alive outside the body for one week. This breakthrough may increase the number of available organs for transplantation saving many lives of patients with severe liver diseases or cancer.

Until now, livers could be stored safely outside the body for only a few hours. With the novel perfusion technology, livers - and even injured livers - can now...

Im Focus: SuperTIGER on its second prowl -- 130,000 feet above Antarctica

A balloon-borne scientific instrument designed to study the origin of cosmic rays is taking its second turn high above the continent of Antarctica three and a half weeks after its launch.

SuperTIGER (Super Trans-Iron Galactic Element Recorder) is designed to measure the rare, heavy elements in cosmic rays that hold clues about their origins...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

„Advanced Battery Power“- Conference, Contributions are welcome!

07.01.2020 | Event News

Latest News

A new 'cool' blue

17.01.2020 | Life Sciences

EU-project SONAR: Better batteries for electricity from renewable energy sources

17.01.2020 | Power and Electrical Engineering

Neuromuscular organoid: It’s contracting!

17.01.2020 | Life Sciences

Science & Research
Overview of more VideoLinks >>>